Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials

Catheterization and Cardiovascular Interventions

Volumn 88, Issue 4, 2016, Pages 501-505

  Elgendy, Islam Y ^a   Wen, Xuerong ^a   Mahmoud, Ahmed ^a   Bavry, Anthony A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

meta analysis; myocardial infarction; percutaneous coronary intervention

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART INFARCTION; HUMAN; INCIDENCE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ADVERSE EFFECTS; AGED; CHEMICALLY INDUCED; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HEMORRHAGE; KIDNEY DISEASE; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PROCEDURES; RECURRENT DISEASE; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTOR;

CONTRAST MEDIUM;

AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEMORRHAGE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84949204547     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26322     Document Type: Article

References (22)

1. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013;369:1115–1123.
2. Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT Trial. J Am Coll Cardiol 2015;65:963–972.
3. Elgendy IY, Huo T, Mahmoud A, Bavry AA. Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. Int J Cardiol 2015;186:98–103.
4. Bangalore S, Toklu B, Wetterslev J. Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: A meta-analysis and trial sequential analysis of randomized trials. Circ Cardiovasc Interv 2015;8:e002142.
5. Hlinomaz O. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: Complete revascularization versus conservative strategy (PRAGUE 13 trial). Presented at the EuroPCR 2015 meeting. Paris, France, May 2015.
6. Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): An open-label, randomised controlled trial. Lancet 2015;386:665–671.
7. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42–46.
8. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009;151:W65–W94.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
10. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
11. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
12. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559–1573.
13. Ghani A, Dambrink JH, van't Hof AW, et al. Treatment of non-culprit lesions detected during primary PCI: Long-term follow-up of a randomised clinical trial. Neth Heart J 2012;20:347–353.
14. Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: Major adverse cardiac events during long-term follow-up. Heart 2010;96:662–667.
15. Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: Results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 2004;6:128–133.
16. Vlaar PJ, Mahmoud KD, Holmes DR Jr, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: A pairwise and network meta-analysis. J Am Coll Cardiol 2011;58:692–703.
17. Moretti C, D'Ascenzo F, Quadri G, et al. Management of multivessel coronary disease in STEMI patients: A systematic review and meta-analysis. Int J Cardiol 2015;179:552–557.
18. Rade JJ. FFR-guided PCI–FAME may not be so fleeting after all. N Engl J Med 2014;371:1251–1253.
19. Shamir M. Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Primary PCI for STEMI, clinicaltrials.gov. National Library of Medicine (US), Bethesda (MD). 2000. Available at: http://clinicaltrials.gov/show/NCT01740479 NLM Identifier: NCT01740479, accessed on 2015 May 22.
20. Bittl JA, Tamis-Holland JE, Lang CD, et al. Outcomes after multivessel or culprit-Vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: A Bayesian cross-design meta-analysis. Catheter Cardiovasc Interv 2015;86(Suppl 1):S15–S22.
21. Jensen LO, Terkelsen CJ, Horvath-Puho E, et al. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction. Am Heart J 2015;170:70–78.
22. Elgendy IY, Conti CR, Bavry AA. Fractional flow reserve: An updated review. Clin Cardiol 2014;37:371–380.